Minor
BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome
Enrollment closed, study ongoing
Also in this update: Final enrollment: 12 participants (planned 24); Primary completion date changed from estimate of Mar 17, 2026 to Oct 10, 2025
Eric Stephen Winer, MDPhase 1 NCT05703542 Registry history of NCT05703542 on ClinicalTrials.gov (opens the registry)